Cohance Lifesciences, through its CRBio division, is a leading provider of end-to-end clinical solutions in the area of Bioavailability & Bioequivalence studies as well as Clinical Trials with a focus on providing quality outcomes to global customers

Best in Class facilities

We are an India-based regulatory class CRO with various global accreditations and approvals. We have state of the art infrastructure in place spread across 25,000+ sq ft facility with 114 beds across 4 independent clinics and state of the art bioanalytical laboratory

Expertise in cross section of clinical research

We have a skilled team of 120 employees with extensive capabilities in handling complex studies, carrying out studies for highly variable molecules and long housing designs, conducting BA&BE studies (including patient-based BA & BE studies, end point and Phase 1B, 2A clinical trials)

Experience and Track record

With over 1000+ BA/BE studies conducted with different types of study designs on various types of dosage forms and 250+ validated bioanalytical methods, we are vastly experienced and best placed to partner customers

Our strength in conducting clinical trials is demonstrated by our database of 15000+ volunteers including 500+ female volunteers

Submissions made to globally reputed regulatory agencies are a testimony to our capabilities, and these include submissions to USFDA, UK MHRA, TPD Health Canada, EMEA, MoH Turkey, NPRA Malaysia, WHO, GCC Riyad, DCGI, MoH Ukraine, SAHPRA – South Africa, TGA – Australia, etc